Novo Ventures leads $49m Series B for anti-acne business Thesan Pharmaceuticals

Biotechnology business Thesan Pharmaceuticals, which aims to treat skin disorders including acne and dermatitis, has picked up $49m of Series B financing led by existing backer Novo Ventures.